| ADT | androgen deprivation therapy |
| ARPI | androgen receptor pathway inhibitor |
| GnRH | gonadotropin-releasing hormone |
| HF | heart failure |
| MACE | major adverse cardiovascular event |
| mCRPC | metastatic castration-resistant prostate cancer |
| NHIRD | National Health Insurance Research Database |
| PCa | prostate cancer |
| RSF | random survival forest |
| VIMP | variable importance |